Skip to main content

Publications

Peer Reviewed Articles

(partial listing, 2013 - present)

  • Panfil AR, Dissinger NJ, Landes K, Fernandez S, Green PL: Functional Comparison of HBZ and the Related APH-2 Protein Provide Insight Into HTLV-1 Pathogenesis. In Press. J Virology.
  • Kawatsuki A, Yasunaga J,Mitobe Y, Green PL, Matsuoka M: HTLV-1 bZIP factor protein targets the Rb/E2F-1 pathway to promote proliferation and apoptosis of primary CD4+ T cells.  Oncogene advance online publication, 25 January 2016; doi:10.1038/onc.2015.510.
  • Panfil AR, Al-Saleem  J, Howard CM, Mates JM, Kwiek JJ, Baiocchi RA, Green PL:Protein arginine methyltransferase 5 is upregulated in HTLV-1-mediated T-cell transformation and selective inhibition alters viral gene expression and infected cell survival.  Viruses  2015 8(1), 7; doi:10.3390/v8010007. PMID:26729154.
  • Cherian MA, Baydoun HH, Al-Saleem J, Shkriabai N, Kvaratskhelia M,  Green PL, Ratner L.  Akt Activation by Human T-Cell Leukemia Virus Tax Oncoprotein.  J Biol Chem  2015  Oct 23;290(43):26270-81 PMID:26324707.
  • Baydoun HH, Cherian MA, Green PL, Ratner L.  Inducible nitric oxide synthase mediates DNA double strand breaks in HTLV-1 induced leukemia/lymphoma. Retrovirology 2015 Aug;12:71. doi: 10.1186/s12977-015-0196-y. PMCID:PMC4534112.
  • Takachi T, Takahashi-Yoshita M, Takahashi M, Higuchi M, Obata M, Mishima Y, Kominami R, Okuda S, Matsuoka M, Saito A, Green PL, Fujii M. Human T-cell leukemia virus type 1 Tax oncoprotein represses expression of the tumor suppressor BCL11B in T-cells. Cancer Science  2015 Apr; 106(4): 461–465 PMCID: PMC4409891.
  • Dissinger N, Shkriabai N, Hess S, Kvaratskhelia M, Green, PL. Identification and Characterization of HTLV-1 1 HBZ Post-Translational Modifications. PLoS ONE. 2014 Nov 12;9(11):e112762. PMCID:PMC4229220.
  • Barrios CS, Disinger N, Green PL, Beilke, MA: Biology, Clinical Features, and Immunology of Human T-cell Leukemia Virus type 2. Current Topics in Virology 11:59-75, 2013.
  • Panfil AR, Al-Saleem JJ, Green PL: Animal models utilized in HTLV-1 research. Virology:Research and Treatment, 4:49-59 2013. PMCID:PMC4222344.
  • Anapum R, Doueiri R, Green PL: The need to accessorize: Molecular roles of HTLV-1 p30 and 1 HTLV-2 p28 accessory proteins in the viral life cycle. Fronteirs in Virology, 2013 Sep 17;4:275 PMCID:PMC3774995.
  • Sharma A, Larue RC, Plumb MR, Malani N, Slaughter A, Kessl JJ, Shkriabai N, Aiyer SS, Green PL, Wu L, Roth MJ, Bushman FD, Kvaratskhelia M: BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc Natl Acad Sci U S A , 2013 Jul 16;110(29):12036-41. PMCID: PMC371817178.
  • Enose-Akahata Y, Abrams A,Massoud R, Bialuk I, Green PL, Maloney EM, Jacobson S. Humoral immune response to HTLV-1 basic leucine zipper factor (HBZ) in HTLV-1-infected individuals. Retrovirology 2013;10(1):19. PMCID:PMC3584941.
  • Kannian P, Fernandez S, Jones KS Green PL: Human T lymphotropic virus type 1 (HTLV-1) SU residue 195 plays a role in determining the preferential CD4+ T cell transformation/transformation tropism. J Virology 2013 Aug;87(16):9344-9352, 2013. PMCID:PMC3754058.